Navigation Links
The Latest Preventative Treatment Option for Prostate Cancer

In a recent study researchers say they have found that the drug toremifene, also known as Fareston, used to treat breast cancer // decreased patients' cancer incidence after 12 months of treatment. All dose levels were found to have some impact, but the 20-milligram dose had the greatest effect.

514 patients in the study had high-grade prostatic intraepithelial neoplasia, characterized by abnormal cells in the lining of the prostate ducts. Patients either received a placebo or a daily dose of toremifene in a 20-milligram, 40-milligram, or 60-milligram amount. Results from 12-month biopsies show a 48-percent reduction in prostate cancer incidence for patients taking the 20-milligram dose of toremifene compared to those on placebo.

Researchers in the current study say: "With no effective treatment options available, doctors and patients often feel defenseless against the onset of prostate cancer. Fortunately, these results offer a promising new preventative approach to prostate treatment. A chemopreventive agent like toremifene is a first step toward the possibility of stopping prostate cancer before it starts and gives patients and doctors a chance to fight this pervasive disease."
'"/>




Page: 1

Related medicine news :

1. Latest device for identifying Melanomas
2. Latest discovery on Autism
3. Latest device for cardiac revival under test
4. Latest technique for asthma treatment
5. Latest drug shows promise in multiple myeloma
6. Latest Findings On The Deadly Disease - SARS
7. Latest Tumor Classification More Informative
8. Latest Research Shows That Multivitamins Might Not Prevent Infections In All Elderly
9. A Latest Study Links Fish To Stroke
10. Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement
11. Lovers Latest Hang Outs – Railway Platform
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is pleased ... Building 2. The clinic is the group’s second in New Braunfels and 22nd in ... second New Braunfels location brings things full circle for the group, “It’s crazy to ...
(Date:3/23/2017)... ... ... are unaware of the dangers that infectious bacteria play in mouth disease, while 1 out ... that dentists recommend. The ramifications of improper oral upkeep go far beyond bad breath and ... hours of work each year due to dental issues. That is why Mediaplanet is proud ...
(Date:3/23/2017)... ... March 23, 2017 , ... The StayWell Company announced ... The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive ... that have excellent programs for the delivery and improvement of disease management and ...
(Date:3/23/2017)... ... March 23, 2017 , ... Michael Lanteri Agency, ... greater Fort Collins area, has unveiled a collaboration with nonprofit Big Bones Canine ... to this worthy cause may now be made at http://bigbonescaninerescue.com/ . , ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ?This conference will prominently feature 150+ Hospital and ... and Director, AMN Healthcare: Susan Salka , 43rd President of the United States ... Big Fight My Life In and Out of the Ring: Sugar Ray Leonard , ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... March 23, 2017 CENTRO DE IMAGEM DIAGNOSTICOS ... paragraph 4 of Law 6,404/76 and Instruction 358/02 of ... its shareholders and the market in general that it ... Centro de Diagnosticos por Imagem Ltda. (" CDI "), ... in RADIOLOGISTAS ASSOCIADOS LTDA. (" Partnership " and " ...
(Date:3/23/2017)... , March 23, 2017  The goal ... system to identify and track prescription drugs as they ... , in response to requirements from US FDA to ... of potentially dangerous medicines. Blockchain startup ... cryptographic identity chips and blockchain technology and recently raised ...
(Date:3/23/2017)... , March 23, 2017  Cornerstone Pharmaceuticals, ... a major milestone today.  Following successful End-of-Phase ... U.S. Food and Drug Administration (FDA), the ... and regulatory path forward to conduct pivotal ... patients with acute myeloid leukemia (AML) and ...
Breaking Medicine Technology: